Chemistry and Biological Activity of the Anti‐HIV Prodrug N4‐Dimethylaminomethylene‐2′,3′‐Dideoxy‐3′‐Fluorocytidine (DDFC) a
Chemistry and Biological Activity of the Anti‐HIV Prodrug N4‐Dimethylaminomethylene‐2′,3′‐Dideoxy‐3′‐Fluorocytidine (DDFC) a
复制标题
抗 HIV 前药 N4-二甲基氨基亚甲基-2,3-二脱氧-3-氟胞苷 (DDFC) 的化学和生物活性
DOI:
--
复制
发表时间:
1990
期刊:
影响因子:
--
通讯作者:
A. V. Reddy
中科院分区:
文献类型:
--
作者:
T. Kalman;A. V. Reddy
This work was undertaken to demonstrate the feasibility of a prodrug approach to the improvement of the therapeutic effectiveness of existing anti-HIV dideoxynucleosides, aiming at more effective penetration into the central nervous system, prolonged duration of action, and decreased cellular and systemic toxicities. DDFC (NSC-614898) was designed and chosen as a representative of this class of agents1 The kinetics of the hydrolysis of the dimethylaminomethylene side chain was investigated using reverse-phase HPLC. At 37°C and pH 7.4 in phosphate buffer, DDFC had a half-life of 4.8 hours. An intermediate containing a conjugated side chain with a retention time of 4.4 min, was observed to rapidly accummulate, reaching a maximum of 10% within 1.5 hours. On the basis of the similarity of its ultraviolet spectrum (determined by a diode-array detector during HPLC analysis) to that of N4acetylcytidine, the intermediate was identified as N4-formyl-3’-F-ddC. A plausible mechanism previously considered2 for the hydrolysis of the dimethylaminomethylene side chain, consistent with our results, is outlined below: